Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Labeling DNA Probes

Labeling DNA Probes

DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Normothermic Regional Perfusion Enables Successful Simultaneous Liver-Kidney Transplantation From DCD Donors: A Preliminary Experience.

Clinical transplantation·2026

Same author

Evaluation of the Prevalence of Occult Fibrin in Donor Organs, Its Origins, and Consequences: Insights From the COPE Studies.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Same author

A pilot, two-center, sequential dose escalation safety study of alteplase with fresh frozen plasma during normothermic liver perfusion.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026

Same author

Normothermic regional perfusion in donation after circulatory determination of death-Confirming the absence of brain reperfusion.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025

Same author

Consensus classification of biliary complications after liver transplantation: guidelines from the BileducTx meeting.

The British journal of surgery·2025

Same author

Expanding Opportunities for Living Donation: Recommendations From the 2023 Santander Summit to Ensure Donor Protections, Informed Decision Making, and Equitable Access.

Transplantation·2024

Same journal

Introduction to pediatric solid organ transplantation - not just little adults!

Current opinion in organ transplantation·2026

Same journal

Editorial introduction.

Current opinion in organ transplantation·2026

Same journal

Precision medicine guided development of new immunosuppression strategies in solid organ transplantation.

Current opinion in organ transplantation·2026

Same journal

Intestinal transplantation for tumors.

Current opinion in organ transplantation·2026

Same journal

Current state of medical rehabilitation for adult short bowel syndrome patients with intestinal failure.

Current opinion in organ transplantation·2026

Same journal

Update on costimulatory blockade in transplantation: a review of recent literature.

Current opinion in organ transplantation·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Active Probe Atomic Force Microscopy with Quattro-Parallel Cantilever Arrays for High-Throughput Large-Scale Sample Inspection

Active Probe Atomic Force Microscopy with Quattro-Parallel Cantilever Arrays for High-Throughput Large-Scale Sample Inspection

Published on: June 13, 2023

Some observations on prope tolerance.

Roy Calne¹, Christopher J E Watson

¹University Department of Surgery, Addenbrooke's Hospital, Cambridge, UK. calne@cam.ac.uk

Current Opinion in Organ Transplantation

|June 14, 2011

Summary

This summary is machine-generated.

Alemtuzumab induction therapy followed by minimal immunosuppression shows a low incidence of rejection and infection in organ transplant patients. This

More Related Videos

A Probing Device for Quantitatively Measuring the Mechanical Properties of Soft Tissues during Arthroscopy

A Probing Device for Quantitatively Measuring the Mechanical Properties of Soft Tissues during Arthroscopy

Published on: May 1, 2020

Whole Mount in Situ Hybridization of E8.5 to E11.5 Mouse Embryos

Whole Mount in Situ Hybridization of E8.5 to E11.5 Mouse Embryos

Published on: October 10, 2011

Related Experiment Videos

Last Updated: Jun 1, 2026

Active Probe Atomic Force Microscopy with Quattro-Parallel Cantilever Arrays for High-Throughput Large-Scale Sample Inspection

Active Probe Atomic Force Microscopy with Quattro-Parallel Cantilever Arrays for High-Throughput Large-Scale Sample Inspection

Published on: June 13, 2023

A Probing Device for Quantitatively Measuring the Mechanical Properties of Soft Tissues during Arthroscopy

A Probing Device for Quantitatively Measuring the Mechanical Properties of Soft Tissues during Arthroscopy

Published on: May 1, 2020

Whole Mount in Situ Hybridization of E8.5 to E11.5 Mouse Embryos

Whole Mount in Situ Hybridization of E8.5 to E11.5 Mouse Embryos

Published on: October 10, 2011

Area of Science:

Transplantation immunology
Immunosuppression strategies

Background:

Organ transplantation requires effective immunosuppression to prevent rejection.
Minimizing long-term immunosuppression can reduce side effects and costs.

Purpose of the Study:

To review the rationale for using alemtuzumab induction therapy.
To discuss the benefits of minimal maintenance immunosuppression post-transplant.

Main Methods:

Utilizing alemtuzumab as a powerful depleting induction agent.
Implementing a 'prope tolerance' protocol with reduced maintenance immunosuppression.

Main Results:

Confirmed low rates of rejection, infection, and post-transplant lymphoproliferative disorder (PTLD).
Positive outcomes observed in African-American recipients.
Treg cells implicated in graft acceptance; reduced transplantation costs noted.

Conclusions:

The alemtuzumab induction and minimal maintenance immunosuppression protocol is effective and well-tolerated.
This approach offers a favorable safety profile and reduced costs.
Minimal maintenance immunosuppression is considered the optimal current therapy for organ transplant patients.